Acute Myeloid Leukaemia

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Clinical Study of U32 in Patients With Acute Myeloid Leukemia

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Leukemia Adapted Protocol

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care

GITMO AML/MDS-Relapse Registry Study

Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia

Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations

WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study